Kenya Medical Research Institute, Kisumu, Kenya.
University of California Berkeley, Berkeley, CA.
J Acquir Immune Defic Syndr. 2024 Jan 1;95(1):74-81. doi: 10.1097/QAI.0000000000003311. Epub 2023 Dec 1.
Persons with HIV (PWH) with high mobility face obstacles to HIV care engagement and viral suppression. We sought to understand whether a patient-centered intervention for mobile PWH would improve viral suppression and retention in care, and if so, which subgroups would benefit most.
In a randomized trial, we evaluated the effect of an intervention designed to address barriers to care among mobile (≥2 weeks out of community in previous year) PWH with viral nonsuppression or recent missed visits in Kenya and Uganda (NCT04810650). The intervention included dynamic choice of a "travel pack" (emergency antiretroviral therapy [ART] supply, discrete ART packaging, and travel checklist), multimonth and offsite refills, facilitated transfer to out-of-community clinics, and hotline access to a mobility coordinator. The primary outcome was viral suppression (<400 copies/mL) at 48 weeks. Secondary outcomes included retention in care and ART possession.
From April 2021 to July 2022, 201 participants were enrolled and randomized (102 intervention, 99 control): 109 (54%) were female participants and 101 (50%) from Kenya; median age was 37 years (interquartile range: 29-43). At 48 weeks, there was no significant difference in viral suppression in intervention (85%) vs. control (86%). The intervention improved retention in care (risk ratio: 1.06[1.02-1.1]; P < 0.001) and ART possession (risk ratio: 1.07[1.03-1.11]; P < 0.001), with larger effect sizes among persons with baseline nonsuppression and high mobility (≥2 weeks out of community in previous 3 months).
Mobile PWH-centered care should be considered for high-risk mobile populations, including nonsuppressed and highly mobile PWH, to improve retention in care and sustain viral suppression over time.
NCT04810650.
具有高流动性的艾滋病毒感染者(PWH)在参与艾滋病毒护理和病毒抑制方面面临障碍。我们试图了解针对流动性强的 PWH 的以患者为中心的干预措施是否会提高病毒抑制率和护理保留率,如果是,哪些亚组将受益最大。
在一项随机试验中,我们评估了一种干预措施的效果,该干预措施旨在解决肯尼亚和乌干达病毒未抑制或最近错过就诊的流动性强的 PWH(≥过去一年中有 2 周不在社区内)的护理障碍(NCT04810650)。该干预措施包括灵活选择“旅行包”(紧急抗逆转录病毒治疗[ART]供应、离散的 ART 包装和旅行清单)、多个月和异地续药、便利转移到社区外诊所以及热线联系流动协调员。主要结局是 48 周时的病毒抑制(<400 拷贝/毫升)。次要结局包括护理保留和 ART 拥有。
从 2021 年 4 月至 2022 年 7 月,共有 201 名参与者入组并随机分组(102 名干预组,99 名对照组):109 名(54%)为女性参与者,101 名(50%)来自肯尼亚;中位年龄为 37 岁(四分位距:29-43)。48 周时,干预组(85%)和对照组(86%)的病毒抑制率无显著差异。干预措施提高了护理保留率(风险比:1.06[1.02-1.1];P<0.001)和 ART 拥有率(风险比:1.07[1.03-1.11];P<0.001),在基线未抑制和高度流动(过去 3 个月中≥2 周不在社区内)的人群中效果更大。
应考虑以移动 PWH 为中心的护理措施,适用于高危移动人群,包括未抑制和高度移动的 PWH,以提高护理保留率,并随着时间的推移持续抑制病毒。
NCT04810650。